3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
6
Neoplasms
6
Cancer Pain
6
Pain, Intractable
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Waldenstrom Macroglobulinemia
1
Vesico-Ureteral Reflux
1
Ureteral Neoplasms
1
Thrombocythemia, Essential
1
Sigmoidal Tumour
1
Sezary Syndrome
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pain, Postoperative
1
Nephrolithiasis
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Mucositis
1
Monoclonal Gammopathy of Undetermined Significance
1
Interventions
Morphine
1
Levobupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Sigmoidal Tumour
×
Morphine
×
Clear all
NCT01825993
2013-04-08
2013/004
Corporacion Parc Tauli
Phase 3
Unknown
225 enrolled